SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India submits board meeting intimation

30 Sep 2023 Evaluate
Novartis India has informed that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2023. In this connection, pursuant to the 'Code of Conduct to regulate, monitor and report share trading by Designated Persons and their immediate relatives' ('Code') read with the applicable provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for dealing in shares of the Company by Designated Persons will be closed with effect from Sunday, October 1, 2023 to Sunday, October 29, 2023.

The above information is a part of company’s filings submitted to BSE.

Novartis Share Price

1000.55 9.25 (0.93%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 220.95
Adani Enterprises 2088.20
Amrapali Industries 17.32
Rashi Peripheral 404.30
PDS 295.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×